Okami Medical, founded in 2011 and based in Aliso Viejo, California, is a company that specializes in developing and commercializing medical devices for the occlusion of peripheral vessels. Their flagship product, the LOBO Vascular Occlusion System, is designed to obstruct or reduce blood flow in arteries of the peripheral vasculature, providing physicians with a stable and efficient solution for a wide range of vascular targets. Led by a management team consisting of Bob Rosenbluth, Brian Cox, and Paul Lubock, Okami Medical focuses on addressing the evolving needs of patients and physicians by creating versatile and intuitive devices that ensure rapid and reliable vessel occlusion, regardless of tortuosity and flow conditions.